NASDAQ
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Open
$5.35
Previous Close
$4.13
Day High
$6.13
Day Low
$5.07
52 Week High
$14.28
52 Week Low
$4.09
No price data available for this timeframe.